Biopharmaceuticals and Biomedicine Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032

Report code : IS289, Status : Published, Published on: Jan, 2020, Pages : 139 Pages, Format : PDF/PPT/Excel

Buying Options

Global Analysis: : $999

Global and Regional Analysis : $2799

Global Deep Dive Analysis : $5499

Competition Analysis : $399

Buy Now

Enquiry before buying

Description

The pharmaceutical giants are focusing on development of biopharmaceuticals through investment in research & development and production of biopharmaceuticals and biomedicines. Biopharmaceuticals has emerged as a prime segment of pharmaceutical industry and has witnessed prominent growth over last couple of years and holds significant growth potential.

Though the cost associated with biopharmaceuticals is significantly high as compared to traditional drugs, rising demand for effective treatment and increasing per capita healthcare expenditure are dynamically shaping the global biopharmaceutical and biomedicine market.

Additionally, increasing research & development expenditure, and rising prevalence of chronic diseases are anticipated to be major factors fueling demand for biopharmaceutical and biomedicines during forecast period.

North America dominated the global biopharmaceutical and biomedicine market owing to rapid transformation of healthcare landscape and steady adoption of biopharmaceuticals.

Additionally, availability of excellent research & development infrastructure in the United States, and streamlined insurance reimbursement policies, are other parameters supporting the growth of North America biopharmaceutical and biomedicine market. Asia Pacific is anticipated to witness steady adoption of biopharmaceutical owing to limited demand from this geography.

Major players dominating the global biopharmaceuticals and biomedicine market include AbbVie Inc., Affimed N.V., Amgen Inc., Bristol - Myers Squibb, Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, NanoString Technologies, Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Qiagen N.V., and Sanofi S.A.

The report titled “Biopharmaceuticals and Biomedicine Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” offers market estimates for a period 2019 to 2032, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global biopharmaceuticals and biomedicine market.

Furthermore, the report would reflect on the key developments, global & regional sales network, business strategies, security & exchange overview, research & development activities, production facilities, product portfolio, employee strength, and key executive, for all the players considered under the scope of study.

For instance, Novartis AG reported revenues of US$ 51,900 Million in 2018 and the segment and geographic analysis of the company indicates Innovative Medicines business segment of the company dominated revenue in 2018 with the United States and Europe generating 69% of total revenue.

The global biopharmaceuticals and biomedicine market is segmented based on type, application, and geography. Based on type, global biopharmaceuticals and biomedicine market is segmented into Nano medicine, cell & gene therapy, system biology, bio informatics, molecular enzymes & kits, and others. Based on application, the global market is segmented into therapeutics, diagnostics, and research & development. Based on geography, the global biopharmaceuticals and biomedicine market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Additionally, the study provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on Biopharmaceuticals and Biomedicine. Further, market share of company in the global biopharmaceuticals and biomedicine market would also be calculated.

For instance, Novartis AG operates through three business divisions namely Innovative Medicines, Sandoz, and Alcon. Biopharmaceuticals and biomedicine are delivered under Sandoz business division of the company with revenue contribution of US$ 9.9 Billion in 2018.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the biopharmaceuticals and biomedicine companies. Furthermore, the global biopharmaceuticals and biomedicine market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.

A portfolio would focus on all the products under the biopharmaceuticals and biomedicine market business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global biopharmaceuticals and biomedicine market arena.

For instance, in December 2018, Novartis AG completed the acquisition of Endocyte, a US-based biopharmaceutical company focused on developing targeted therapeutics for cancer treatment at approximately US$ 2.1 billion. Key players in the global biopharmaceuticals and biomedicine market are strongly focusing on developing advanced biopharmaceuticals and biomedicine to cater the rising demand from global market.

Market Segmentation:

By Type

By Application

therapeutics
diagnostics
research & development

By Geography

North America
Europe
Asia Pacific
Middle East & Africa
South America

Table Of Content

Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
Market Synopsis: Global Biopharmaceuticals and Biomedicine Market
Global Biopharmaceuticals and Biomedicine Market Qualitative Analysis
- Ecosystem Analysis
  - Role of participants
  - Integration scenario
- Trends
  - Market trends
  - Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
  - Driving Forces
  - Hindering Forces
  - Opportunities
- COVID-19 consequences
Global Biopharmaceuticals and Biomedicine Market Analysis and Forecast, by Product Type
- Overview and definitions
- Key segment analysis
- Global Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Product Type, 2019 – 2032
  - Biopharmaceutical
    - Monoclonal Antibodies
    - Vaccines
    - Recombinant Human Insulin
    - Human Growth Hormone
    - Erythropoietin
    - Interferon
    - Colony Stimulating Factor
    - Blood Factors
    - Fusion Protein
    - Others
  - Nanomedicine
  - Cell & Gene Therapy
  - Bioinformatics
  - Molecular Enzymes & Kits

Global Biopharmaceuticals and Biomedicine Market Analysis and Forecast, by Application
- Overview and definitions
- Key segment analysis
- Global Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Oncology
  - Neuroscience
  - Infectious disease
  - Immunology
  - Hematology
  - Hemophilia
  - Ophthalmology
  - Respiratory
  - Others

Global Biopharmaceuticals and Biomedicine Market Analysis and Forecast, by Application
- Overview and definitions
- Key segment analysis
- Global Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Therapeutics
  - Diagnostics
  - Research & Development

Global Biopharmaceuticals and Biomedicine Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Region, 2019 – 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Biopharmaceuticals and Biomedicine Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Product Type, 2019 – 2032
  - Biopharmaceutical
    - Monoclonal Antibodies
    - Vaccines
    - Recombinant Human Insulin
    - Human Growth Hormone
    - Erythropoietin
    - Interferon
    - Colony Stimulating Factor
    - Blood Factors
    - Fusion Protein
    - Others
  - Nanomedicine
  - Cell & Gene Therapy
  - Bioinformatics
  - Molecular Enzymes & Kits
- North America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Disease Type, 2019 – 2032
  - Oncology
  - Neuroscience
  - Infectious disease
  - Immunology
  - Hematology
  - Hemophilia
  - Ophthalmology
  - Respiratory
  - Others
- North America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Therapeutics
  - Diagnostics
  - Research & Development
- North America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), Country, 2019 – 2032
  - United States
  - Canada
  - Rest of North America

Europe Biopharmaceuticals and Biomedicine Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Product Type, 2019 – 2032
  - Biopharmaceutical
    - Monoclonal Antibodies
    - Vaccines
    - Recombinant Human Insulin
    - Human Growth Hormone
    - Erythropoietin
    - Interferon
    - Colony Stimulating Factor
    - Blood Factors
    - Fusion Protein
    - Others
  - Nanomedicine
  - Cell & Gene Therapy
  - Bioinformatics
  - Molecular Enzymes & Kits
- Europe Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Disease Type, 2019 – 2032
  - Oncology
  - Neuroscience
  - Infectious disease
  - Immunology
  - Hematology
  - Hemophilia
  - Ophthalmology
  - Respiratory
  - Others
- Europe Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Therapeutics
  - Diagnostics
  - Research & Development
- Europe Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), Country, 2019 – 2032
  - Germany
  - United Kingdom
  - France
  - Italy
  - Spain
  - Rest of Europe

Asia Pacific Biopharmaceuticals and Biomedicine Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Product Type, 2019 – 2032
  - Biopharmaceutical
    - Monoclonal Antibodies
    - Vaccines
    - Recombinant Human Insulin
    - Human Growth Hormone
    - Erythropoietin
    - Interferon
    - Colony Stimulating Factor
    - Blood Factors
    - Fusion Protein
    - Others
  - Nanomedicine
  - Cell & Gene Therapy
  - Bioinformatics
  - Molecular Enzymes & Kits
- Asia Pacific Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Disease Type, 2019 – 2032
  - Oncology
  - Neuroscience
  - Infectious disease
  - Immunology
  - Hematology
  - Hemophilia
  - Ophthalmology
  - Respiratory
  - Others
- Asia Pacific Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Therapeutics
  - Diagnostics
  - Research & Development
- Asia Pacific Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), Country, 2019 – 2032
  - Japan
  - India
  - China
  - Australia
  - Rest of Asia Pacific

Middle East & Africa Biopharmaceuticals and Biomedicine Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Product Type, 2019 – 2032
  - Biopharmaceutical
    - Monoclonal Antibodies
    - Vaccines
    - Recombinant Human Insulin
    - Human Growth Hormone
    - Erythropoietin
    - Interferon
    - Colony Stimulating Factor
    - Blood Factors
    - Fusion Protein
    - Others
  - Nanomedicine
  - Cell & Gene Therapy
  - Bioinformatics
  - Molecular Enzymes & Kits
- Middle East & Africa Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Disease Type, 2019 – 2032
  - Oncology
  - Neuroscience
  - Infectious disease
  - Immunology
  - Hematology
  - Hemophilia
  - Ophthalmology
  - Respiratory
  - Others
- Middle East & Africa Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Therapeutics
  - Diagnostics
  - Research & Development
- Middle East & Africa Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), Country, 2019 – 2032
  - Saudi Arabia
  - UAE
  - South Africa
  - Rest of Middle East

South America Biopharmaceuticals and Biomedicine Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Product Type, 2019 – 2032
  - Biopharmaceutical
    - Monoclonal Antibodies
    - Vaccines
    - Recombinant Human Insulin
    - Human Growth Hormone
    - Erythropoietin
    - Interferon
    - Colony Stimulating Factor
    - Blood Factors
    - Fusion Protein
    - Others
  - Nanomedicine
  - Cell & Gene Therapy
  - Bioinformatics
  - Molecular Enzymes & Kits
- South America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Disease Type, 2019 – 2032
  - Oncology
  - Neuroscience
  - Infectious disease
  - Immunology
  - Hematology
  - Hemophilia
  - Ophthalmology
  - Respiratory
  - Others
- South America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Therapeutics
  - Diagnostics
  - Research & Development
- South America Biopharmaceuticals and Biomedicine Market Estimates (US$ Mn), Country, 2019 – 2032
  - Brazil
  - Rest of South America

Competition Analysis – Biopharmaceuticals and Biomedicine Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
  - AbbVie Inc.
    - Business overview
    - Geographic presence
    - Product portfolio
    - Financial facts
    - Channel partners
    - Relevant news and strategic view
  - Affimed N.V.
  - Amgen Inc.
  - Bristol - Myers Squibb
  - Eli Lilly and Company
  - Hoffmann-La Roche AG
  - Johnson & Johnson
  - NanoString Technologies, Inc.
  - Novartis AG
  - Novo Nordisk A/S
  - Pfizer, Inc.
  - Qiagen N.V.
  - Sanofi S.A.
  - GSK plc.
  - Merck KGaA
  - Teva Pharmaceutical Industries Ltd.

Conclusion & Recommendations

Request Sample

Request for Customization

Call with the Author

Frequently asked questions about this report

What are the growth prospects of biopharmaceutical and biomedicines market?

Increasing research & development expenditure, and rising prevalence of chronic diseases are anticipated to be major factors fueling demand for biopharmaceutical and biomedicines during forecast period. The global biopharmaceutical and biomedicines market is anticipated to witness significant growth during the forecast period.

How is the regional performance of the biopharmaceutical and biomedicines market?

North America dominated the global biopharmaceutical and biomedicine market owing to rapid transformation of healthcare landscape and steady adoption of biopharmaceuticals.

What are the different types of biopharmaceutical and biomedicines used?

Based on type, the biopharmaceutical and biomedicines market is segmented into Nano medicine, cell & gene therapy, system biology, bio informatics, molecular enzymes & kits, and others

Who are the prominent market players in the market?

AbbVie Inc., Affimed N.V., Amgen Inc., Bristol - Myers Squibb, Celgene Corporation are the top 5 Biopharmaceuticals and Biomedicine manufacturers.